Evidence map›Paper›PMID 41011066›Full record

ArticleMedicina (Kaunas, Lithuania)2025

The Effect of HER2 Status on Gastric Cancer Survival and the Clinical Implications of the HER2-Low Definition: A Retrospective Study.

Mehmet Uzun, Savas Gokcek, Melis Kilinc, Ferhat Ekinci, Tugay Avci, Atike Pinar Erdogan, Elif Atag, Ilkay Tugba Unek

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mehmet UzunDepartment of Medical Oncology, Health Sciences University, Tepecik Training and Research Hospital, 35180 Izmir, Turkey.ORCID 0000-0002-8596-4233
Savas GokcekDepartment of Medical Oncology, Necip Fazıl City Hospital, 46050 Kahramanmaras, Turkey.
Melis KilincDepartment of Internal Medicine, Buca Seyfi Demirsoy Training and Research Hospital, 35360 Izmir, Turkey.ORCID 0000-0002-4288-9632
Ferhat EkinciFaculty of Medicine, Medical Oncology Department, Manisa Celal Bayar University, 45020 Manisa, Turkey.ORCID 0000-0002-9317-942X
Tugay AvciFaculty of Medicine, Medical Oncology Department, Manisa Celal Bayar University, 45020 Manisa, Turkey.ORCID 0000-0001-9652-7058
Atike Pinar ErdoganFaculty of Medicine, Medical Oncology Department, Manisa Celal Bayar University, 45020 Manisa, Turkey.ORCID 0000-0003-4859-7574
Elif AtagDepartment of Medical Oncology, Dokuz Eylül University, 35340 Izmir, Turkey.
Ilkay Tugba UnekDepartment of Medical Oncology, Dokuz Eylül University, 35340 Izmir, Turkey.ORCID 0000-0002-9124-6123

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaErb-b2 Receptor Tyrosine KinasesStomach NeoplasmsAdultAgedAged, 80 and overFemaleHumansImmunohistochemistryIn Situ Hybridization, FluorescenceKaplan-Meier EstimateMaleMiddle AgedRetrospective StudiesERBB2 protein, humanErb-b2 Receptor Tyrosine Kinasesadvanced gastric cancerHER-2 expressionHER-2 lowmetastatic patternsoverall survival

Identifiers

PMID41011066
PMCPMC12471298

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.